TABLE 1.
Patient characteristics
| Docetaxel (breast cancer) (n = 28) | Oxaliplatin (colorectal cancer) (n = 35) | P value | |
|---|---|---|---|
| Age at follow‐up, years, mean (SD) | 57.0 (7.2) | 68.9 (6.6) | < .001 |
| Age at first cycle of chemotherapy, years, mean (SD) | 52.2 (7.2) | 63.9 (6.6) | < .001 |
| Mean time since first treatment, years, mean (SD) | 4.8 (0.4) | 5.1 (0.4) | .01 |
| Females, No. (%) | 28 (100.0) | 12 (34.3) | < .001 |
| Height, cm, mean (SD) | 167.4 (5.1) | 173.7 (8.0) | < .001 |
| Weight, kg, mean (SD) | 78.8 (17.1) | 79.2 (12.4) | .91 |
| Body mass index (kg/m2), mean (SD) | 28.0 (5.6) | 26.3 (4.0) | .15 |
| Diabetes, No. (%) | 3 (10.7) | 3 (8.6) | 1.00 |
| Cumulative dose (mg), mean (SD) | 580.3 (186.3) | 1150.7 (435.3) | < .001 |
| Cumulative dose/body area (mg/m2), mean (SD) | 306.6 (89.5) | 608.1 (227.5) | < .001 |
| Endocrine therapy, No. (%) | 19 (67.9) | ||
| Smoking, No. (%) | 1.00 | ||
| Yes, No. (%) | 3 (10.7) | 3 (8.8) | |
| Never, No. (%) | 12 (42.9) | 14 (41.2) | |
| Former smoker, No. (%) | 13 (46.4) | 17 (50.0) | |
| Alcohol above >7/14 units for women/men, No. (%) | 4 (15.4) | 5 (15.6) | 1.00 |